Standard BioTools Inc. files S-4/A
- Filed S-4/A on 2026-10-09
- Merger with Treeline Biosciences
- Exchange ratio of 11.7157 shares
LAB
STANDARD BIOTOOLS INC. SEC filings
Every EDGAR filing for STANDARD BIOTOOLS INC. (LAB), newest first, with AI summaries and stories.
- Ticker
- LAB
- CIK
- 1162194
- Sector
- Biotech and pharma
- Latest filing
- Oct 9
Next: earnings expected ~Nov 5 ยท 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINES-4/ASTANDARD BIOTOOLS INC.LABLIVE ROUTINE425STANDARD BIOTOOLS INC.LABLIVE Standard BioTools sells Microfluidics to ARCHIMED
- Agreement to sell Microfluidics business to ARCHIMED
- Transaction expected to close in 30 days
- ARCHIMED is a healthcare-focused investment firm
ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE Standard BioTools sells Microfluidics to ARCHIMED
- Agreement signed on Oct 5, 2026
- Sale expected to close in 30 days
- ARCHIMED is a healthcare-focused investment firm
ROUTINE425STANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINES-4/ASTANDARD BIOTOOLS INC.LABLIVE ROUTINE4STANDARD BIOTOOLS INC.LABLIVE 3 insider filings
Sean Mackay, insider filing for LAB
Show all 3
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
Sean Mackay, reporting
ROUTINESCHEDULE 13G/ASTANDARD BIOTOOLS INC.LABLIVE Ownership stake disclosure by MAK CAPITAL ONE LLC (amended)
MAK CAPITAL ONE LLC, filed by
ROUTINESCHEDULE 13GSTANDARD BIOTOOLS INC.LABLIVE Ownership stake disclosure by Long Focus Capital Management, LLC
Long Focus Capital Management, LLC, filed by
ROUTINES-8STANDARD BIOTOOLS INC.LABLIVE ROUTINES-8STANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE NOTABLE10-QSTANDARD BIOTOOLS INC.LABLIVE ROUTINE4STANDARD BIOTOOLS INC.LABLIVE Michael Egholm, insider filing for LAB
Michael Egholm, reporting
ROUTINESCHEDULE 13G/ASTANDARD BIOTOOLS INC.LABLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE425STANDARD BIOTOOLS INC.LABLIVE ROUTINE8-K/ASTANDARD BIOTOOLS INC.LABLIVE ROUTINE425STANDARD BIOTOOLS INC.LABLIVE ROUTINE425STANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINE4STANDARD BIOTOOLS INC.LABLIVE Hanjoon Alex Kim, insider filing for LAB
Hanjoon Alex Kim, reporting
ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINE425STANDARD BIOTOOLS INC.LABLIVE NOTABLES-4STANDARD BIOTOOLS INC.LABLIVE ROUTINE4STANDARD BIOTOOLS INC.LABLIVE 7 insider filings
Thomas D. Carey, insider filing for LAB
Show all 7
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
Thomas D. Carey, reporting
ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE NOTABLESCHEDULE 13DSTANDARD BIOTOOLS INC.LABLIVE Ownership stake disclosure by VIKING GLOBAL INVESTORS LP
VIKING GLOBAL INVESTORS LP, filed by
NOTABLESCHEDULE 13D/ASTANDARD BIOTOOLS INC.LABLIVE Ownership stake disclosure by Casdin Capital, LLC (amended)
Casdin Capital, LLC, filed by
ROUTINE425STANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINESDSTANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINE4STANDARD BIOTOOLS INC.LABLIVE 3 insider filings
Hanjoon Alex Kim, insider filing for LAB
Show all 3
- 4Insider filing for LAB
- 4Insider filing for LAB
- 4Insider filing for LAB
Hanjoon Alex Kim, reporting
ROUTINESCHEDULE 13G/ASTANDARD BIOTOOLS INC.LABLIVE 2 13G filings
Ownership stake disclosure by MAK Capital Fund LP (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
MAK Capital Fund LP, filed by
NOTABLE10-QSTANDARD BIOTOOLS INC.LABLIVE ROUTINE8-KSTANDARD BIOTOOLS INC.LABLIVE ROUTINEDEFA14ASTANDARD BIOTOOLS INC.LABLIVE